The Fed is expected to cut rates Wednesday, but it is unlikely to tell markets what they want to hear on future rate cuts.Market Insiderread more
The trade war between the United States and China has lasted for more than one year — and a resolution is nowhere in sight.World Economyread more
Pelosi said Trump should not have tried to address China's trade practices in a way that opened Americans up to financial pain.Politicsread more
On Sept. 18, Capital One and Walmart announced the launch of the Capital One Walmart Rewards Credit Card Program, which offers two new cobranded credit cards. Here's a break...Moneyread more
TransferWise posted an annual net profit of £10.3 million on revenues of £179 million.Technologyread more
Here's CNBC review of the Apple Watch Series 5, which makes a step forward with an always-on display and a useful compass that can help you find your way on Apple Maps.Technologyread more
Live the high life with a night's stay at Highclere Castle, the iconic stately home made famous by Downton Abbey.Spendread more
President Donald Trump doesn't want war with Iran — but Tehran seems inclined to "test the Trump administration," says Gerald Feierstein, a former U.S. Ambassador to Yemen.Oilread more
Large banking institutions face the risk of failure if interest rates in Europe continue to stay negative, warns the global chief economist of the Economist Intelligence Unit.Banksread more
The fallout from two fatal crashes of Boeing 737 Max planes has ensnared the manufacturer's most-loyal customer: Southwest Airlines. The carrier has canceled thousands of...Airlinesread more
In the survey, conducted after the third in the Democratic Party's series of debate, the former vice president draws 31% compared to 25% for the Massachusetts senator. At 14%,...2020 Electionsread more
No beer for you, Martin.
"Pharma bro" Martin Shkreli planned on stopping by a Brooklyn bar for happy hour immediately after his hearing in Brooklyn Federal Court Friday afternoon.
Two minutes after his first tweet asking for suggestions, he invited his "fans" to meet up with him at Henry Street Ale House, and offered to pay for drinks.
The bar put a stop to that almost immediately after he invited his 154,000 Twitter followers to join him. Shkreli is accused of looting the pharma company Retrophin of $11 million to pay off investors he was suspected of previously defrauding in a hedge fund he ran.
Apparently, the Brooklyn Heights establishment did not approve of Shkreli's self-invitation, and in a tweet (that has since been deleted) said Shkreli and his "fans" were not welcome.
The bar followed up with a couple of tweets explaining and defending the decision.
The bar's manager told CNBC, "We're a small place, and we operate a restaurant ... We're not a big bar," he said. "This has nothing to do with politics, but this is a controversial figure... We're a low-key place, we needed advance notice."
The manager, who asked that his name not be used in the story, also said Shkreli reached out and apologized.
It didn't take long for the accused fraudster to find a new place. Shkreli now plans to be at Brooklyn Public House shortly after his hearing.
Shkreli first drew public attention and scorn last year after his new company, Turing Pharmaceuticals, abruptly raised the price of the drug Daraprim, used to treat toxoplasmosis, by more than 5,500 percent. Daraprim's sticker price jumped from $13.50 per pill to $750 per pill overnight.
He repeatedly defended the increase as justified, even as critics noted that pregnant women, babies and people infected with the HIV virus are primary patients of the medication.
Although the price hike drew widespread outrage, it had nothing to do with the criminal charges that were subsequently lodged against him.
In February, Shkreli refused to testify before a congressional committee investigating drug price increases, citing his Fifth Amendment right against self-incrimination.
Please check back for updates on Shkreli's hearing later Friday.
—CNBC's Dan Mangan contributed to this report